Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Probiotec.
RELATED STOCKHEAD STORIES
News
2024: All the latest broker moves
Experts
MoneyTalks: The most irresistible ASX small cap takeover targets in 2024
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Health & Biotech
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
Health & Biotech
These are the ASX stocks Morgans thinks can push the health and wellness agenda
Health & Biotech
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Health & Biotech
ASX Health Stocks: Most biotechs are still chasing maiden revenue, but here’s a few healthcare stocks with strong earnings
Escrow Watch
ASX Escrow Watch: Which lithium plays are releasing shares heading into 2023?
Health & Biotech
ASX Health Stocks: Giant Sonic and small cap Probiotic roll out the record results
Director Trades
Director Trades: Which telco director got a $9 million+ pay day?
Health & Biotech
ASX Health Stocks: Results show revenue is growing in first half, but profitability still elusive
Health & Biotech
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ScoPo’s Powerplays: Biogen drama, M&A action, and profit-taking coloured the week in healthcare
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Experts
Microcap magic: From iron ore to edtech (and IPOs) with Annapurna’s Stephen Scott
News
